Last reviewed · How we verify
NCT06840028
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
NA trial testing mHealth/sFitRx in Cancer Survivors in 160 participants. Currently enrolling.
1 September 2025
Quick facts
| Lead sponsor | The University of Tennessee, Knoxville |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 160 |
| Start date | 1 March 2025 |
| Primary completion | 1 September 2025 |
| Estimated completion | 1 March 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- mHealth/sFitRx
- Fitness Tracker
Conditions studied
- Cancer Survivors — all drugs for Cancer Survivors →
- Chronic Disease — all drugs for Chronic Disease →
- Physical Activity — all drugs for Physical Activity →
- Cancer Survivorship — all drugs for Cancer Survivorship →
Sponsor
The University of Tennessee, Knoxville
Who can join
18 and older, any sex, with Cancer Survivors or Chronic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Participation in regular physical activity is vital to a healthy lifestyle. Research has shown that regular participation in physical activity among cancer survivors is not only able to improve health outcomes, but is also related to their quality of life. As we live in an age of technology, health wearables and smartphone apps might be one novel manner by which to help cancer survivors increase physical activity as well as improve health outcomes. Yet, the effectiveness of wearable and app as a tool for health promotion among cancer survivors is largely unstudied. The purpose of this study is to evaluate the effectiveness of a personalized m-health intervention via fitness wearable (Fitbit Inspire 3) exercise app (sFitRx) on physical activity, weight, quality of life, individual beliefs, and emotions among cancer survivors.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06840028
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer Survivors
Currently open trials in the same condition.
- NCT06778122 — In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors · NA · recruiting
- NCT05179408 — Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer · NA · recruiting
- NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
- NCT06769165 — EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors · NA · recruiting
- NCT06904495 — Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age · NA · recruiting
Other The University of Tennessee, Knoxville trials
Trials by the same sponsor.
- NCT07207993 — Evaluating Health Outcomes of AI-Based Fitness Wearables & App Programs in Elderly With Cognitive Decline · NA · not yet recruiting
- NCT06722261 — Single Case Research Design: Deaf Children's Language Outcomes · NA · active not recruiting
- NCT07023822 — WISH, Feasibility of a Factorial Design · NA · active not recruiting
- NCT06729164 — Strategic and Interactive Signing Instruction Experiment · NA · active not recruiting
- NCT06774573 — Treating Young Adult Generalized Anxiety Disorder With Text-Message Delivered Cognitive Behavioral Therapy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06840028 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Tennessee, Knoxville
- Last refreshed: 27 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06840028.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing